ArticleThe Journal of surgical research2017

Doxorubicin effect is enhanced by sphingosine-1-phosphate signaling antagonist in breast cancer.

Eriko Katsuta et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.